Systemic and inhaled fluoroquinolone antibiotics – reminder on restrictions of use

Table of contents

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Active substance
Fluoroquinolones
Therapeutic area (MeSH)
Anti-Bacterial Agents
Procedure number
SC01/EMA/2018/29/PE
Regulatory outcome
Variation
DHPC type
Post-authorisation measure
Referral name
Quinolone- and fluoroquinolone-containing medicinal products
Dissemination date
08/06/2023

How useful was this page?

Add your rating